Cite
HARVARD Citation
Glintborg, B. et al. (n.d.). THU0123 Non-Medical Switch from Originator To Biosimilar Infliximab among Patients with Inflammatory Rheumatic Disease – Impact on S-Infliximab and Antidrug-Antibodies. Results from The National Danish Rheumatologic Biobank and The Danbio Registry. Annals of the rheumatic diseases. p. 224. [Online].